Gainers

• Soligenix (NASDAQ:SNGX) shares moved upwards by 96.9% to $1.01 during Wednesday's regular session. The market value of their outstanding shares is at $7.6 million.
• BioRestorative Therapies (NASDAQ:BRTX) stock rose 77.74% to $0.44. The market value of their outstanding shares is at $6.3 million.
• AIM ImmunoTech (AMEX:AIM) stock rose 76.36% to $0.41. The company's market cap stands at $3.3 million.
• Q32 Bio (NASDAQ:QTTB) shares moved upwards by 67.56% to $11.88. The market value of their outstanding shares is at $120.2 million.
• Hoth Therapeutics (NASDAQ:HOTH) shares moved upwards by 67.3% to $1.19. The market value of their outstanding shares is at $13.5 million.
• Nanoviricides (AMEX:NNVC) shares rose 23.5% to $1.86. The company's market cap stands at $34.3 million.

Losers

• Geovax Labs (NASDAQ:GOVX) stock fell 24.1% to $2.65 during Wednesday's regular session. The market value of their outstanding shares is at $12.1 million.
• Aditxt (NASDAQ:ADTX) stock decreased by 22.99% to $0.2.
• Co-Diagnostics (NASDAQ:CODX) shares declined by 21.96% to $7.11. The market value of their outstanding shares is at $33.3 million.
• HCW Biologics (NASDAQ:HCWB) stock decreased by 21.79% to $2.05. The company's market cap stands at $17.6 million.
• Mesa Laboratories (NASDAQ:MLAB) stock decreased by 20.77% to $84.12. The company's market cap stands at $586.5 million. As per the press release, Q4 earnings came out today.
• Tevogen Bio Holdings (NASDAQ:TVGN) stock fell 19.66% to $6.91. The market value of their outstanding shares is at $36.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.